๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Hamlet BioPharma AB (publ) (XSAT:HAMLET.B)
Sweden flag Sweden ยท Delayed Price ยท Currency is SEK
6.08
+0.10 (1.67%)
At close: Sep 30, 2026

Hamlet BioPharma AB Financials Overview

Millions SEK. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
0-0.21-2.349.96
Revenue Growth
-99.22%----76.53%6.97%
Gross Profit
0-0.21-2.349.96
Operating Income
-55.23-55.84-55.13-42.56-20.54-17.12
Net Income
-54.96-55.56-54.65-41.82-20.44-17.2
Earnings Per Share
--0.30-0.31-0.25-0.18-0.16
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
16.415.0910.7623.118.3939.61
Total Debt
----5-
Net Cash (Debt)
16.415.0910.7623.113.3939.61
Net Cash Growth
-42.53%-52.69%-53.42%72.49%-66.19%2589.16%
Net Cash Per Share
-0.030.060.140.120.36

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-46.49-44.28-38.83-36-19.61-20.32
Capital Expenditures
-0.35-0.35-0.02-0.28-9.98-
Free Cash Flow
-46.84-44.63-38.85-36.28-29.59-20.32
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%-100.00%-100.00%100.00%
Operating Margin
-3400971.30%--26497.83%--878.36%-171.87%
Pretax Margin
-3384540.46%--26270.61%--874.19%-172.63%
Profit Margin
-3384540.46%--26270.61%--874.19%-172.63%
FCF Margin
-2884350.49%--18676.37%--1265.39%-203.95%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
697031.23-3523.16-124.5842.58